RNA Splicing Events in Circulation Distinguish Individuals With and Without New-onset Type 1 Diabetes

被引:1
|
作者
Webb-Robertson, Bobbie-Jo M. [1 ]
Wu, Wenting [2 ]
Flores, Javier E. [1 ]
Bramer, Lisa M. [1 ]
Syed, Farooq [2 ]
Tersey, Sarah A. [3 ,4 ]
May, Sarah C. [3 ,4 ]
Sims, Emily K. [2 ]
Evans-Molina, Carmella [2 ,5 ]
Mirmira, Raghavendra G. [3 ,4 ]
机构
[1] Pacific Northwest Natl Lab, Biol Sci Div, Richland, WA 99354 USA
[2] Indiana Univ Sch Med, Ctr Diabet & Metab Dis, Indianapolis, IN 46202 USA
[3] Univ Chicago, Diabet Res & Training Ctr, Chicago, IL 60637 USA
[4] Univ Chicago, Dept Med, Chicago, IL 60637 USA
[5] Roudebush Vet Affairs Med Ctr, Indianapolis, IN 46202 USA
基金
美国国家卫生研究院;
关键词
type; 1; diabetes; machine learning; alternative RNA splicing; biomarkers; RECEPTOR;
D O I
10.1210/clinem/dgae622
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Alterations in RNA splicing may influence protein isoform diversity that contributes to or reflects the pathophysiology of certain diseases. Whereas specific RNA splicing events in pancreatic islets have been investigated in models of inflammation in vitro, how RNA splicing in the circulation correlates with or is reflective of type 1 diabetes (T1D) disease pathophysiology in humans remains unexplored.Objective To use machine learning to investigate if alternative RNA splicing events differ between individuals with and without new-onset T1D and to determine if these splicing events provide insight into T1D pathophysiology.Methods RNA deep sequencing was performed on whole blood samples from 2 independent cohorts: a training cohort consisting of 12 individuals with new-onset T1D and 12 age- and sex-matched nondiabetic controls and a validation cohort of the same size and demographics. Machine learning analysis was used to identify specific isoforms that could distinguish individuals with T1D from controls.Results Distinct patterns of RNA splicing differentiated participants with T1D from unaffected controls. Notably, certain splicing events, particularly involving retained introns, showed significant association with T1D. Machine learning analysis using these splicing events as features from the training cohort demonstrated high accuracy in distinguishing between T1D subjects and controls in the validation cohort. Gene Ontology pathway enrichment analysis of the retained intron category showed evidence for a systemic viral response in T1D subjects.Conclusion Alternative RNA splicing events in whole blood are significantly enriched in individuals with new-onset T1D and can effectively distinguish these individuals from unaffected controls. Our findings also suggest that RNA splicing profiles offer the potential to provide insights into disease pathogenesis.
引用
收藏
页码:1148 / 1157
页数:10
相关论文
共 50 条
  • [41] Brief report: Depression and history of suicide attempts in adults with new-onset Type 2 Diabetes
    Myers, Alyson K.
    Grannemann, Bruce D.
    Lingvay, Ildiko
    Trivedi, Madhukar H.
    PSYCHONEUROENDOCRINOLOGY, 2013, 38 (11) : 2810 - 2814
  • [42] Anti-SARS-CoV-2 antibodies in new-onset type 1 diabetes in children during pandemic in Belgium
    Messaaoui, Anissa
    Hajselova, Lucia
    Tenoutasse, Sylvie
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2021, 34 (10) : 1319 - 1322
  • [43] Mean platelet volume and glycaemic control in patients with new-onset Type 2 diabetes mellitus
    Gulia, Manisha
    Gupta, Monica
    Lehl, Sarabmeet Singh
    Singla, Mandeep
    Tahlan, Anita
    Kaur, Jasbinder
    JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH, 2022, 52 (02) : 105 - 109
  • [44] High levels of blood circulating immune checkpoint molecules in children with new-onset type 1 diabetes are associated with the risk of developing an additional autoimmune disease
    Bruzzaniti, Sara
    Piemonte, Erica
    Mozzillo, Enza
    Bruzzese, Dario
    Lepore, Maria Teresa
    Carbone, Fortunata
    de Candia, Paola
    Strollo, Rocky
    Porcellini, Antonio
    Marigliano, Marco
    Maffeis, Claudio
    Bifulco, Maurizio
    Ludvigsson, Johnny
    Franzese, Adriana
    Matarese, Giuseppe
    Galgani, Mario
    DIABETOLOGIA, 2022, 65 (08) : 1390 - 1397
  • [45] Plasma Calprotectin and New-onset Type 2 Diabetes in the General Population: A Prospective Cohort Study
    Bourgonje, Arno R.
    Bourgonje, Martin F.
    Sokooti, Sara
    la Bastide-van Gemert, Sacha
    Nilsen, Tom
    Hidden, Clara
    Gansevoort, Ron T.
    Mulder, Douwe J.
    Hillebrands, Jan-Luuk
    Bakker, Stephan J. L.
    van Beek, Andre P.
    Dullaart, Robin P. F.
    van Goor, Harry
    Abdulle, Amaal E.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, 110 (01) : e150 - e159
  • [46] The COVID-19 Pandemic Increased the Incidence of New-Onset Type One Diabetes in Children
    Blumenfeld, Orit
    Rozenshmidt, Mikhail
    Eini, Idan
    Laron, Zvi
    CHILDREN-BASEL, 2024, 11 (02):
  • [47] Alpha-1 antitrypsin treatment of new-onset type 1 diabetes: An open-label, phase I clinical trial (RETAIN) to assess safety and pharmacokinetics
    Weir, Gordon C.
    Ehlers, Mario R.
    Harris, Kristina M.
    Kanaparthi, Sai
    Long, Alice
    Phippard, Deborah
    Weiner, Lia J.
    Jepson, Brett
    McNamara, James G.
    Koulmanda, Maria
    Strom, Terry B.
    PEDIATRIC DIABETES, 2018, 19 (05) : 945 - 954
  • [48] Impact of COVID-19 in New-Onset Type 1 Diabetes Mellitus in a Large Portuguese Pediatric Diabetes Center
    Caetano, Francisco Branco
    Lanca, Ana
    Rodrigues, Claudia
    Bota, Sofia
    Garcia, Ana Margarida
    Diamantino, Catarina
    Fitas, Ana Laura
    Galhardo, Julia
    Pina, Rosa
    Lopes, Lurdes
    Limbert, Catarina
    REVISTA PORTUGUESA DE ENDOCRINOLOGIA DIABETES E METABOLISMO, 2022, 17 (3-4) : 97 - 101
  • [49] Healthcare cost of type 1 diabetes mellitus in new-onset children in a hospital compared to an outpatient setting
    Jasinski, Christopher F.
    Rodriguez-Monguio, Rosa
    Tonyushkina, Ksenia
    Allen, Holley
    BMC PEDIATRICS, 2013, 13
  • [50] Healthcare cost of type 1 diabetes mellitus in new-onset children in a hospital compared to an outpatient setting
    Christopher F Jasinski
    Rosa Rodriguez-Monguio
    Ksenia Tonyushkina
    Holley Allen
    BMC Pediatrics, 13